z-logo
open-access-imgOpen Access
Human immunodeficiency virus and renal transplantation
Author(s) -
Rajani Dinavahi,
Anita Mehrotra,
Barbara Murphy,
Shirish Huprikar
Publication year - 2009
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2009.184
Subject(s) - transplantation , human immunodeficiency virus (hiv) , medicine , virology , kidney transplantation , immunology , intensive care medicine
CASE PRESENTATIONA 48-year-old African-American man with chronic human immunodeficiency virus (HIV) infection since 1987 was referred to our center for renal transplant evaluation. HIV-associated nephropathy had been diagnosed 8 years earlier by renal biopsy. Hemodialysis had been initiated 3 years earlier. Past medical history was significant for hypertension and hyperlipidemia. Before transplantation, total cholesterol was 178mg per 100ml, low-density lipoprotein was 40mg per 100ml, and high-density lipoprotein was 67mg per 100ml without lipid-lowering therapy. The patient reported no history of earlier opportunistic infection (OI), malignancy, or co-infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). He had been treated with highly active antiretroviral therapy (HAART) since 1990. After numerous treatment failures, virologic suppression was finally achieved with a combination of lamivudine, abacavir, efavirenz, and lopinavir/ritonavir

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom